Application note: Enrichment of high titer CHO clones
A selective FACS-enrichment was performed via the enrichment mode of Namocell Single Cell Dispenser to enrich for high titer CHO cells.
List view / Grid view
A selective FACS-enrichment was performed via the enrichment mode of Namocell Single Cell Dispenser to enrich for high titer CHO cells.
Watch Dr David Rimm from the Yale School of Medicine talk about his recent work and take on the future of multiplex spatial profiling of the TME.
By creating a drug that is based on part of the SARS-CoV-2 spike protein, US and Finnish researchers can block the virus from entering cells.
To help people with opioid addiction, US researchers are turning to AI to create and optimise potential new drugs.
Explore pathways of cell cycle control, revealing mechanisms of cell cycle arrest, DNA damage and senescence using this ebook.
Japanese researchers combine cutting edge mass spectrometry with software analysis to elucidate mRNA structure.
Oestrogen receptors play a crucial role in breast cancer. By making them therapeutic targets, oestrogen can be regulated with the aim to prevent breast cancer.
US researchers evaluate an experimental gene therapy in the first ever nonhuman primate model for Usher Syndrome.
US researchers investigate how bacteria develop an antibiotic tolerance without mutations.
Discover how the Agilent Seahorse XF Real Time ATP rate assay provides a simple robust workflow that can identify metabolic targets for drug discovery
US researchers spotlight how p53, the most frequently mutated tumour suppressor gene, can be activated against cancer cells.
In this article Drug Target Review's Izzy Wood highlights three of the latest findings using lab automation techniques and technologies that aid scientists.
Australian researchers have uncovered why some forms of Streptococcus A (Strep A) are associated with severe invasive infection.
In this exclusive article, Drug Target Review’s Izzy Wood highlights ground-breaking ovarian cancer research, after speaking with Dr Benjamin Neuditschko, from the Institute Krems Bioanalytics at IMC Krems.
US researchers uncover the amino acid: arginine, that prompts genetic mutations in cancer cells.